A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NCT07086339 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-03-13
Summary
A Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema
Conditions
- COPD
- Emphysema
Interventions
- DEVICE
-
Implantable pulmonary stent
Implantable polymer based pulmonary stent for severe COPD/emphysema
Sponsors & Collaborators
-
Pulmair Medical, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-04
- Primary Completion
- 2027-08-31
- Completion
- 2027-12-31
Countries
- France
- Netherlands
Study Locations
More Related Trials
-
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
NCT01559051 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
NCT05321082 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD
NCT06731959 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
NCT01266317 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3
-
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
NCT00035828 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
NCT04631016 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
NCT03422068 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Health Study II
NCT00000569 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT02538536 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321069 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
NCT05785624 ·Status: TERMINATED ·Phase: PHASE2
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
NCT05897424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Single Use Bronchoscopes for Interventional Pulmonology
NCT06596655 ·Status: RECRUITING ·Phase: NA
-
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis
NCT06280391 ·Status: COMPLETED ·Phase: PHASE2
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
NCT06959095 ·Status: RECRUITING ·Phase: PHASE3
-
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
NCT04456673 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
NCT02096315 ·Status: TERMINATED ·Phase: PHASE2
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321420 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
NCT04656275 ·Status: TERMINATED ·Phase: PHASE1
-
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
NCT00993707 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of the Spiration IBV™ System
NCT00145548 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172300 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT01254409 ·Status: COMPLETED ·Phase: PHASE1